Find clinical trials for Non-Hodgkin Lymphoma in Salt Lake City, UT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Salt Lake City, UT, USA:
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Salt Lake City, Utah, United States and 34 other locations
The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...
Phase 3
Salt Lake City, Utah, United States and 186 other locations
Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood ce...
Phase 1
West Valley City, Utah, United States and 3 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 31 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Salt Lake City, Utah, United States and 34 other locations
purpose of this clinical trial is to learn if the study drug pemigatinib is effective in treating patients with relapsed or refractory B-cell non...
Phase 2
Salt Lake City, Utah, United States
(CAR) targeting CD19 in pediatric patients with relapsed or refractory (r/r) B cell acute lymphoblastic leukemia (B ALL) and r/r B cell Non- ...
Phase 1
Salt Lake City, Utah, United States and 5 other locations
clinical trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 20 other locations
This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 14 other locations
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 40 other locations
Clinical trials
Research sites
Resources
Legal